Publications
Most Food Labeling Class Actions Remain Stayed While FDA Process Runs ‘Natural’ Course
October 23, 2017
Consumer class actions over the use of the term ‘‘natural’’ on product labels should be stayed in deference to the Food and Drug Administration’s ongoing consideration of regulatory action, Sidley lawyers Amy Lally and Amanda Farfel say. The large number of comments received by the FDA on the topic reflects the complexity of the issues and the need for expert guidance from the agency the authors say.
Capabilities
Suggested News & Insights
Update on English Legal Advice Privilege Following the Aabar Holdings v Glencore JudgmentMay 20, 2026Sidley Advises Big 12 Conference on Partnership With RedBird Capital PartnersMay 15, 2026Sidley Wins “Innovative Lawyers in Disputes” Award at the FT Innovative Lawyers Awards Asia-Pacific 2026May 14, 2026Sidley Represents Rigel Pharmaceuticals in Exclusive Global License Agreement with Pfizer and Arvinas for VEPPANUMay 13, 2026Sidley Ranked in Benchmark Litigation Asia-Pacific 2026May 13, 2026When “The Devil Made Me Do It” Is Not a Defense: Lessons in AI Governance and Organizational Oversight from an SDNY DecisionMay 11, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
